Role of the phosphatidylinositol 3′;-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells

Cancer Research

Volumn 62, Issue 17, 2002, Pages 4929-4937

  Kandasamy, Karthikeyan ^a   Srivastava, Rakesh K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYTOCHROME C; MESSENGER RNA; MUTANT PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BID; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; WORTMANNIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MITOCHONDRION; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 9; CASPASES; CELL SURVIVAL; DOWN-REGULATION; HUMANS; INTRACELLULAR MEMBRANES; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MEMBRANE POTENTIALS; MITOCHONDRIA; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 0036731976     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Cancer statistics, 2001
2. Cancer statistics, 2000
3. Lung cancer heterogeneity: A blinded and randomized study of 100 consecutive cases
4. Targets for molecular intervention in multistep pulmonary carcinogenesis
5. Chemotherapy for advanced non-small cell lung cancer
6. New agents within the preoperative chemotherapy of non-small cell lung cancer
7. TRAIL/Apo-2L: Mechanisms and clinical applications in cancer
8. Intracellular mechanisms of TRAIL and its role in cancer therapy
9. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
10. The TRAIL to selective tumor death
11. Intracellular mechanisms of TRAIL: Apoptosis through mitochondrial-dependent and -independent pathways
12. TRAIL a molecule with multiple receptors and control mechanisms
13. Signalling by proteolysis: Death receptors induce apoptosis
14. Mitochondria and apoptosis
15. Molecular characterization of mitochondrial apoptosis-inducing factor
16. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
17. Identification of DIABLO. A mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
18. Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells
19. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
20. Sensitization of AIDS-Kaposi’s sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D
21. Cellular survival: A play in three Akts
22. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
23. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity
24. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway
25. Effect of phosphoinositide-dependent kinase I on protein kinase B translocation and its subsequent activation
26. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
27. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2
28. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells
29. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
30. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
31. Regulation of cell death protease caspase-9 by phosphorylation
32. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit
33. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
34. The lipid phosphatase activity of PTEN is critical for its tumor supressor function
35. PTEN a tumour suppressor that functions as a phospholipid phosphatase
36. PTEN a unique tumor suppressor gene
37. Impaired Fas response and autoimmunity in Pten+/-mice
38. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway
39. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
40. The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling
41. Akt/Protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation
42. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways
43. Regulation of protein kinase B/Akt-serine-473 phosphorylation by integrin linked kinase (ILK): Critical roles for kinase activity and amino acids arginine-211 and serine-343
44. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer
45. Mitochondrial control of cell death
46. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
47. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation
48. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon
49. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma
50. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
51. Identification of a human Akt3 (protein kinase Bγ) which contains the regulatory serine phosphorylation site
52. Growth factor signaling in cell survival: Implications for cancer treatment
53. Wortmannin inhibits PKB/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice
54. Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax
55. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: Inhibition by PKB/Akt but not Raf signalling
56. Akt regulates cell survival and apoptosis at a postmitochondrial level
57. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria
58. Negative regulation of the forkhead transcription factor FKHR by Akt
59. PTEN life as a tumor suppressor
60. PTEN a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
61. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts
62. PTEN sometimes taking it off can be better than putting it on
63. 1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway